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FOREWORD 
The research detailed in this thesis will be submitted to the journal of Clinical 
Autonomic Research, an international peer-reviewed journal for research and treatment 
related to autonomic function and dysfunction owned by Springer, a subsidiary of Springer-
Verlag GmbH, and published by Dr. Dietrich Steinkopff Verlad.   
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ABSTRACT 
THE EFFECTS OF A MULTI-FLAVONOID SUPPLEMENT ON CARDIAC 
AUTONOMIC REGULATION (May 2012) 
Hannah Elizabeth Wheeler, B.S., Appalachian State University 
M.S., Appalachian State University, Boone 
Chairperson: Scott R. Collier 
Antioxidant supplementation has been shown to stimulate positive effects on 
cardiovascular health including a reduction in blood pressure (BP) by alleviating arterial 
stiffness, but little is known of the benefits of antioxidants on the autonomic nervous system 
(ANS). The ANS plays a role in regulating BP via changes in vagal tone. Aerobic exercise 
has proven to be very beneficial to the ANS by reducing sympathetic modulation and 
increasing vagal modulation providing an overall antiarrhythmic effect on the heart [28]. 
Purpose  This study aims to look at the effects of a multi-flavanoid supplement combined 
with an acute bout of exercise and its effects on heart rate variability and autonomic function 
in pre-hypertensive, middle-aged individuals. Methods  20 pre-hypertensive middle-aged 
individuals between 40-60 years were randomly assigned to the placebo (50.778 ± 1.829 
years, n =10) or treatment group (51.667 ± 1.829 years, n =10). The multi-flavonoid 
antioxidant supplement included 1000 mg quercetin, 120 mg epigallocatechin 3-gallate 
(EGCG), 400 mg isoquercetin, and 400 mg omega-3 fatty acids.  Subjects reported to the lab 
for baseline measurements. Beat-to-beat BP was measured on each subjects left arm and 
heart rate (HR) was monitored using a three lead electrocardiogram (CM5 configuration) to 
attain low frequency (LF), high frequency (HF), total power (TP), and other cardiac 
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autonomic modulation variables. Subjects were lying on a motorized tilt table in a quiet, 
dimly lit room, supine for 5 minutes, tilted head-up for 5 minutes and were lying supine 
again for 5 minutes, while measurements were being taken. Subjects supplemented for two 
weeks and returned for post measurements, identical to the procedure used earlier. Results  
There was a statistically significant decrease in normalized low frequency (nLF) in the 
treatment group (pre 0.647 ± .064 to post 0.567 ± 0.045, p > 0.05), with no changes in the 
placebo group (pre 0.483 ± 0.077 to post 0.556 ± 0.061 p > 0.05), pre to post 
supplementation. There was a large increase in normalized high frequency (nHF) in the 
treatment group (pre 0.342 ± 0.08 to post 0.417 ± 0.07, p = 0.07), but it was not statistically 
significant. There were no significant changes in total power (TP), root mean squared of the 
standard deviation between successive ventricular depolarization (R-R) intervals (RMSSD), 
or the area differences between R-R intervals (pNN50) for both treatment and placebo. There 
was a large decrease in percent (%) change in LF:HF ratio after tilt in the treatment group, 
but it was not significant. Conclusion  The multi-flavonoid antioxidant supplementation 
showed favorable effects on the ANS by lowering the sympathetic outflow, and there was no 
additive effect of exercise and supplementation following the acute bout of aerobic exercise.   
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                                                         INTRODUCTION 
 The autonomic nervous system (ANS) integrates two divisions (sympathetic and 
parasympathetic) of the central nervous system (CNS) to regulate cardiovascular responses 
and adaptations to varying physiological and environmental conditions. Heart rate variability 
(HRV) is the variation of both instantaneous heart rate (HR), or the distance between 
successive ventricular depolarization (R-R) intervals [on an electrocardiogram (EKG)] and 
can be used to measure cardiac autonomic function. Recently, HRV has become a promising 
marker to help associate increased sympathetic activity or reduced vagal tone with lethal 
arrhythmias, which develop as a result of cardiovascular disease (CVD) [15].  Reductions in 
HRV have been correlated with the development of many cardiovascular conditions; 
whereas, a HR with wide variability that is responsive to stressors is believed to grant a 
survival advantage. In contrast, reduced HRV is found in many different diseased 
populations such as diabetics, those who have suffered myocardial infarctions, and those with 
hypertension or other CVD [15]. All of these diseases, which result in increased sympathetic 
drive, can lead to a fatal, sudden arrhythmia  [24]. This autonomic dysfunction is a result of 
dysregulation of both branches of the ANS. Regular aerobic exercise has been shown to 
increase parasympathetic influence, thereby reducing blood pressure (BP) and eliciting 
numerous benefits on overall cardiovascular health in adults. In those who are borderline 
hypertensive, it has been reported that an acute bout of exercise can reduce systolic (SBP) 
and diastolic blood pressure (DBP) 10 and 16 mmHg, respectively [11]. The speculated 
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mechanisms for blood pressure reductions during post exercise hypotension could be part 
by increased parasympathetic outflow coupled with peripheral vasodilation.  
 The reduction in BP in response to exercise may be related to improvements in 
autonomic function due to the positive effects both mechanisms elicit after exercise [9].  
Previous studies have shown that exercise training increases vagal tone by inducing resting 
bradycardia, indicating that exercise can produce an antiarryhthmic effect [24]. Furthermore, 
it has been demonstrated that those who aerobically train display an overall higher HRV and 
a lower mean resting heart rate compared to those who are sedentary [12]. Overall, higher 
HRV equates to enhanced vagal activity, thereby reducing myocardial demand in central BP.  
 While reductions in BP following exercise training are often linked to increases in 
parasympathetic tone, new strategies in BP reduction study the combination of aerobic 
exercise and dietary antioxidant supplementation for a potential additive effect. Antioxidant 
supplementation has been shown to improve arterial elasticity which, in turn, can help lower 
BP and increase baroreflex sensitivity in middle aged individuals [26]. Quercetin is a type of 
flavonoid antioxidant derived from plant pigment found in many different types of fruits and 
vegetables. Quercetin has been shown to help with asthma, inflammation, and with the 
prevention of CVD. Shanely et al. have shown that quercetin alone is ineffective in 
decreasing oxidative stress; however, it has been speculated that combinations of several 
antioxidants may result in greater absorption into the bloodstream which would result in 
greater BP benefits [25]. Therefore, the purpose of this study was to investigate a 
combination supplement that included the antioxidants quercetin, iso-quercetin, and 
epigallocatechin 3-gallate (EGCG) with omega-3 fatty acids (from fish oil) on HRV in 
response to an acute bout of aerobic exercise. We hypothesized that the combination of both 
3 
 
antioxidant supplementation and aerobic exercise would decrease overall sympathetic input, 
increase parasympathetic input and thus increase HRV. 
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METHODS 
Subjects 
 Twenty healthy, pre-hypertensive (BP > 120/80) males and females between the ages 
of 40-60 years (10 men, 10 women) were recruited for this study. Subjects were not currently 
prescribed antihypertension or any other medication, were non-smokers, and had no risk 
factors for CVD. Both pre and post menopausal women were recruited; however, pre-
menopausal women were measured during the identical phase of menstruation as their pre-
measures.  Before participation, each subject completed a health history questionnaire and 
was fully informed of the nature of the study. Participants then provided written consent to 
participate.  
Research Design 
 Each subject reported to the lab on three different occasions. The first visit included 
the completion of a health history questionnaire and informed consent and a laboratory 
familiarization.  Each subject then had a baseline BP measurement manually recorded along 
with descriptive measures of height, weight and body composition (BIA). The subject then 
performed a maximal exercise test (VO2 max) to assess fitness capacity and determine 
maximal exercise HR. For visit two, each subject came to the lab 3-4 hours postprandial and 
had weight, bioelectrical impedance analysis (BIA), and baseline BP measurements were 
taken like in visit one. BP and HR were continuously measured both supine and during 
heads-up, 80 degree tilt in 5 minute epochs. The subject then performed 30 minutes of 
aerobic exercise on a treadmill at 65-70% of previously determined maximal HR. After the 
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completion of the exercise, a post exercise BP was taken, and the previous measurements on 
the tilt table were repeated. At the end of visit two, subjects were randomly assigned to either 
the treatment (Trt) or the placebo (Pla) group. The supplement included the active ingredients 
quercetin, iso-quercetin, EGCG, and omega-3 fatty acids from fish oil. The placebo was 
identical in composition as previously mentioned, without the active ingredients. Subjects 
underwent supplementation for two weeks and were instructed to ingest four chews; two 
chews in the morning and at night for six weeks before returning for visit three. Subjects then 
reported to the lab and completed the identical procedure from visit two to compare pre- and 
post- supplementation measurements. Each subject completed a total of two, three-day food 
diet records before visits two and three. Each set of records was completed on two weekdays 
and one weekend to assess diet.  
Procedures  
 HRV 
 All HRV measurements from our laboratory have been previously described [5]. To 
measure beat-to-beat HR, subjects were monitored on a three lead EKG (CM5 configuration) 
and a sampling rate of 1000 Hz, to analyze R-R intervals and obtain statistical measures such 
as root mean squared of successive differences (RMSSD) and spectral analysis including 
total power (TP), high frequency (HF), low frequency (LF) and the ratio of low frequency 
and high frequency (LF:HF ratio) variables. All data were stored off line on a computer to be 
analyzed at a later time. Data were visually inspected for ectopic beats and artifacts and 
linearly interpolated to provide a continuous data stream. HR peaks were automatically 
detected via an established QRS (atrial to ventricle depolarization and repolarization) 
detection algorithm and used to generate an R-R interval time event series (WinCPRS; 
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Absolute Aliens Oy, Turku, Finland). Data were continuously streamed and resampled at 5 
Hz and passed through a low-pass filter with a cutoff frequency of 0.5 Hz [6]. Power spectral 
analysis was performed using a maximum entropy method [2]. The optimum order of the 
autoregressive model was determined by Akaike’s information criterion. This method 
yielded a model order greater than 16 to avoid possible shifting of the spectral peaks [3].  
 The power was calculated by measuring the area under the peak of the power spectral 
density curve. Three peaks were revealed and their corresponding bandwidths defined as 
follows: an HF region (0.15 - 0.40 Hz) caused by arrhythmic respiratory oscillations that is 
indicative of parasympathetic modulation of the heart; an LF region (0.04 - 0.15 Hz) related 
to baroreflex activity and thermoregulatory components that is mediated by both the 
sympathetic and parasympathetic arms of the ANS; and a very-LF component (< 0.04 Hz) 
resulting from non-harmonic fractal oscillations of unknown origin [15]. The very-LF 
component (VLF) was not used in this study other than in the calculation of normalized LF 
and HF HRV. The power spectra were calculated in both absolute and normalized units to 
represent the relative value of each power component as a proportion of the TP. TP was 
taken as an index of overall variability and was used as a global marker of vagal modulation  
[19]. The LF:HF ratio was used as an indicator of sympathovagal balance [18]. All data 
acquisition and post-acquisition analyses were carried out in accordance with standards put 
forth by the Task Force of the European Society of Cardiology and North American Society 
of Pacing and Electrophysiology [15].  
 Blood pressure 
 Beat-to-beat BP was measured using an upper arm cuff placed on the left arm and a 
finger plethysmography placed on the middle finger of the left hand (Finometer; FMS, 
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Amsterdam, the Netherlands). The finometer is a non-invasive technique that measures beat-
to-beat BP wave forms through the pulse in the finger to analyze hemodynamic parameters 
such as cardiac output (CO), HR. and BP. 
 Tilt Testing 
 While beat-to-beat HR and BP were being measured, subjects were lying supine on a 
tilt table for 5 minutes, tilted head-up at 80 degrees for 5 minutes, and returned to supine for 
5 minutes to assess HR and BP responses to a head-up tilt. An 80 degree head-up tilt was in 
accordance to Sharma et al. who determined that a 70 degree head-up tilt was enough to elicit 
a change in HRV and an increase in sympathetic predominance compared to lying supine 
[27]. Therefore, 80 degrees should be able to elicit the same response. 
 Descriptive Characteristics  
 All blood pressure measurements were attained using a manual BP cuff and a 
sphygmomanometer. Height and weight were both measured using a manual weight scale. 
BIA was measured using the Tanita scale (Tanita, Arlington Heights, Illinois, USA).  
 Graded Exercise Testing 
 A VO2 max text was performed using the modified Balke protocol [22]. Subjects 
began walking at a comfortable speed for two minutes. During the test, intensity was 
increased by increasing speed, until a comfortable pace was met. The grade was then 
increased by 2% every two minutes until the subject reached volitional fatigue. HR was 
recorded every two minutes using a Polar Heart Rate Monitor (Polar Electro, Woodbury, NY, 
USA). A rating of perceived exertion (RPE) was also assessed per each stage using 6-20 
Borg Scale[4]. Expired gas was analyzed using a breath by breath metabolic system 
(ParvoMedics, Sandy, Utah). Maximal effort was attained when subjects reached three of the 
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following four criteria:  (1) respiratory exchange ratio (RER) > 1.15; (2) RPE of 17 or 
greater; (3) volitional fatigue; and (4) or greater than 85% of max. 
Treatment of the data 
 All data were analyzed by SPSS version 19.0 (IBM Armonk, NY) using a two by two 
ANOVA with repeated measures group by time (pre versus post supplementation and 
placebo versus supplement group). If significance was found, an appropriate post hoc test 
was employed. Significance was set at p < 0.05. 
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RESULTS 
Subjects 
 Subject characteristics by group are presented in Table 1. No significant differences 
were found between groups for any variables measured.  
Heart rate variability                                                                                                                
 Pre and post supplementation data are presented in Table 2. Before the exercise 
intervention, there was a significant interaction between both the Trt and Pla groups in 
normalized LF (nLF). A univariate test was run to determine where the underlying 
significance occurred, and a significant decrease was discovered in nLF from pre to post 
supplementation (pre 0.647 ± .064 to post 0.567 ± 0.045, p = 0.05), indicating an overall 
decrease in sympathetic input. However, there was no significant change in the Pla group 
(pre 0.483 ± 0.077 to post 0.556 ± 0.061, p > .05; Figure 1). There was an overall increase in 
normalized HF (nHF) (pre 0.342 ± 0.08 to post 0.417 ± 0.07, p = 0.07) after treatment and 
before the exercise intervention in the Trt group indicating an increase in parasympathetic 
input. However, the change was not statistically significant. Changes to nHF in the Pla group 
were not significantly different (pre 0.415 ± 0.08 to post 0.418 ± 0.07, p > 0.05). There were 
overall increases in RMSSD pre-exercise and after treatment, indicating increases in 
variability, but there were no statistically significant differences (pre 36.3 ± 8.71 to post 44.5 
± 11.55, p > 0.05). There was a large drop in RMSSD (Figure 2) pre-exercise for the Pla 
group, indicating a decrease in variability, but again there was no significant difference (pre 
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50.9 ± 21.84 to post 38.5 ± 9.23, p > 0.05). There was no significant difference in the area 
differences between R-R intervals (pNN50) pre-exercise and after treatment for both the Trt 
group (pre 14.39 ± 6.83 to post 15.5 ± 6.58, p > 0.05) and the Pla group (pre 17.79 ± 8.94 to 
post 10.21 ± 2.68, p > 0.05). There was a large increase in TP for the Trt group (pre 1676.9 ± 
1476 to post 1809.4 ± 1973, p > 0.05), and a large decrease for the Pla group (pre 1726.2 ± 
643.7 to post 959.3 ± 134.2, p > 0.05), respectively, but no significant differences were found 
after treatment and before exercise. When the subjects underwent the head-up tilt there was a 
large increase in the differences in LF:HF ratio pre to post supplementation before exercise 
for both the Trt (supine 113.21 ± 254.6 to tilt 456.93 ± 1381, p > 0.05) and Pla (supine 
152.91 ± 523.5 to tilt 433.96 ± 1162.1, p > 0.05) group, but the increase was not statistically 
significant. When the subjects underwent the head-up tilt after exercise, there was no 
significant difference in the differences in LF:HF ratio pre to post supplementation for the Trt 
group (Figure 3A) or the Pla group (Figure 3B), although there was a large decrease in the 
change in LF:HF ratio for both groups.  
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Table 1. Subject characteristics  
Variables  Treatment Mean SE ± Placebo Mean SE ± 
Age (years) 51.667 ± 1.829 50.778 ± 1.829 
Height (in) 65.583 ± 1.09 68.083 ± 1.049 
Weight (kg)  69.911 ± 5.295 78.289 ± 5.295 
BMI (kg/m²) 25.396 ± 1.498 25.952 ± 1.498 
BIA (%) 29.144 ± 3.109 27.744 ± 3.109 
VO2 peak (ml/kg/min) 33.056 ± 8.768 36.789 ± 7.655 
 
All data are reported as mean ± standard (SE) for n = 20. Baseline values were taken at the 
initial lab visit. BMI body mass index, BIA bioelectrical impedance analysis, VO2 peak 
aerobic fitness   
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Table 2. Autonomic variable changes between treatment groups  
 
 Treatment Placebo 
 Pre-exercise Post-exercise Pre-exercise Post-exercise 
nHF 0.342 ± 0.084 0.417 ± 0.065 0.415 ± 0.084 0.418 ± 0.065 
RMSSD (ms) 36.3 ± 16.627 44.5 ± 10.455 50.9 ± 16.627 38.5 ± 10.455 
pN550 (%) 14.39 ± 7.596 15.5 ± 5.027 17.79 ± 7.956 10.21 ± 5.027 
TP (ms) 1676.9 ± 562.363 1809.4 ± 451.268 1726.2 ± 562.363 959.3 ± 451.268 
 
All data reported as mean ± standard error (SE) for n = 20. nHF normalized high frequency, 
RMSSD root mean squared of successive differences,  pNN50 area differences between R-R 
intervals, TP total power 
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Figure 1. Values reported as mean ± standard error (SE) for n = 20. nLF normalized Low 
Frequency, determined by heart rate variability (HRV), changes from pre to post 
supplementation (p < 0.05); pre pre-supplementation; post post-supplementation  
* nLF significantly decreased pre to post p < 0.05 
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Figure 2. Values reported as mean ± standard error (SE) for n = 20. RMSSD Root Mean 
Square of Successive Differences, determined by heart rate variability (HRV) measurements, 
changes from pre to post supplementation (p > 0.05); pre pre-supplementation; post post-
supplementation  
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Figure 3. Values reported as mean ± standard error (SE) for n = 20. Percent (%) changes in 
LF:HF ratio pre to post supplementation while lying supine and during tilt for the treatment 
(p > 0.05; A) and placebo (p > 0.05; B) groups. 
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                                                           DISCUSSION 
 The main findings of our study have shown favorable benefits in cardiac autonomic 
modulation by decreasing nLF and favorably lowering central BP. These beneficial 
reductions in central hemodynamics may decrease the incidence of all causes mortality, 
arrhythmias, and sudden cardiac death as well the progression of hypertension.                   
 Our study supports other finding including Edwards et al. who showed that 
supplementation with 730 mg/day of quercetin could reduce systolic, diastolic, and mean 
arterial pressure in pre-hypertensive individuals [7].  Other recent studies have also reported 
that quercetin significantly decreases SBP and plasma low density lipoprotein (LDL) 
concentrations in 25- 50 year old hypertensive subjects over a 6 week period of 
supplementation [8].  These previous studies support our study results indicating reductions 
in BP following antioxidant dosing. The overall reduction in BP may be due to the decrease 
in sympathetic outflow and an increase in overall variability.                                     
 In a four week aerobic exercise program, middle-aged individuals demonstrated a 
decrease in LF power, indicating an overall decrease in sympathetic modulation [5]. 
Although our study demonstrated a trend toward decreases in nLF in middle-aged pre-
hypertensive individuals, this trend was only found post supplementation. Yet the acute bout 
of exercise showed no additive effect. This may be due to the fact that an acute bout of 
exercise is not enough to elicit an effect on the ANS, and long term exercise training may be 
more beneficial. Alom et al. conducted a study with adolescent males (12-18 years) and 
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observed that a regular exercise training program over a year induced a resting bradycardia, 
which is associated with changes as well as adaptations in the ANS [1].  
 While sympathetic markers showed an overall decrease, our study found no 
significant changes in nHF. Similar studies using exercise training as a treatment condition 
have resulted in decreases in HF modulation which have been reported to induce resting 
bradycardia [24]. The result of aerobic exercise training has been known to increase vagal 
tone which, in turn, has been proven to result in an antiarryhthmic sinus rhythm [24]. 
Sandercock et al. also reported increased power in the HF component which consequentially 
presents a greater parasympathetic input in response to exercise [24]. Our study results 
coincide with Sandercock et al. showing an increase in nHF post exercise, which is clinically 
significant, yet our sample size was determined to be to small to achieve statistical 
significance [24].    
 When expressing our HRV in time domain measures, our study showed no significant 
additive effects in TP, pNN50, or RMSSD with the combination of supplementation and 
exercise. A similar study by Raczak et al. with young, untrained male subjects performing a 
single bout of mild exercise without supplementation showed increases in several 
parasympathetic measurements including standard deviation between R-R intervals in the 
time domain (SDNN; from 81 ± 44 milliseconds to 96 ± 53 milliseconds), pNN50 (from 43 ± 
27 % to 48 ± 26 %), and RMSSD (from 89 ± 66 milliseconds to 109 ± 90 milliseconds) [23]. 
Although large increases were observed in all of these variables, the changes were only 
significant with SDNN (p = 0.02). These data suggest that even mild physical activity has a 
positive autonomic affect, since the SDNN variation increased with exercise training. Our 
study demonstrated large increases in RMSSD, pNN50, and TP in the treatment group, 
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indicating an increase in overall variability, yet our findings were not statistically significant 
due to the large standard errors and small sample size. 
 Head-up tilting is an orthostatic tolerance test and ANS stressor predominantly used 
to measure clinical autonomic function and HRV. Sharma et al., using a perturbation of  a 70 
degree head-up tilt, showed that HF power significantly decreases during tilt which decreases 
vagal dominance, lending to increases in sympathetic stimulation [27]. This group also 
showed significant decreases in pNN50 corresponding to short term HRV changes. These are 
considered normal responses in a physiological system that is making instantaneous changes 
in an effort to maintain homeostasis. With age, the ANS has a decline in functioning leading 
to decreased sensitivity of postural changes altering the autonomic responses. Aging 
responses have been documented, and Laitinen et al. compared young individuals, middle-
aged, and elderly subjects and concluded that as humans age, there is a decrease in TP, LF, 
and HF to a 70 degree head-up tilt [14]. The decrease in LF power was also significantly less 
when compared to younger subjects. In our study, the Trt group demonstrated less 
sympathetic influence during the head-up tilt test post supplementation. Although the scale of 
change in LF:HF ratio was not significant, the small decrease in sympathetic response could 
be due to a lysing of sympathetic outflow, resulting in decreased BP. La Rovere et al. used a 
similar tilt table test to evaluate trained and untrained subjects who had suffered a myocardial 
infarction [13]. The conclusion was that exercise training led to significantly greater LF 
increases and significantly greater HF decreases during the tilt. Limited data exist on the 
effects of an acute bout of aerobic exercise on an individual’s autonomic response while 
undergoing an ANS stressor, yet La Rovere et al. suggests that trained patients who had  
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suffered a myocardial infarction (MI) had a functionally favorable ANS response during the 
tilt test compared with those who were untrained [13].                                                           
 Our supplement was a combination of multiple antioxidants including quercetin, iso-
quercetin, EGCG, and omega-3 fatty acids from fish oil. It is controversial whether the 
combination of several antioxidants may be more tolerable and culminate in greater 
physiological benefits when compared to single antioxidant treatments. However, flavonoids 
like EGCG have been shown to exert a positive effect on endothelial function which supports 
less arterial resistance and favorable decreases in resting BP. Being able to prevent and 
potentially treat arterial endothelial damage may  help decrease the clinical manifestitation of 
elevated BP and resting HR, leading to greater HRV in pre-hypertensive adults [29]. Our 
supplement also contained omega-3 fatty acids which have been shown to produce favorable 
blood high density lipoprotein (HDL) profiles which in turn may help prevent and treat 
atherosclerotic plaques.  In a recent study by Mozaffarian et al. healthy individuals > 65 
years consumed fish and omega-3 fatty acids over the period of a year and showed a greater 
shift towards vagal predominance as well as improvements in baroreflex sensitivity (BRS) 
[17]. There were also increases in HF power as well as decreases in LF:HF ratio; thus fish oil 
could also potentially elicit improvements in HRV and reduce CVD risk factors. Also, a 
meta-analysis performed on clinical trials using supplementation of fish oil revealed a 
significant reduction in HR in humans of 1.6 beats per minute after supplementation for two 
supplement durations [16]. The decrease in HR with fish oil suggests that n-3 fatty acids 
possess a positive altering effect on at least one of the components that can help decrease 
cardiovascular risk. However, there have been no beneficial results shown with omega-3 
fatty acid supplementation on any HRV variables. Park et al. found  no association with 
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beneficial effects of omega-3 fatty acid as a sole supplement as an endpoint on autonomic 
function following the consumption of omega-3 fatty acids [20].                                
 Additional studies on quercetin as a single dietary supplement have failed to show 
positive results on adult cardiovascular function following a supplementation regimen of 500 
or 1000 mg [25]. A study performed with the dietary supplementation of quercetin using 1 
gram per day dosage in apparently healthy subjects’ for four weeks showed increased 
quercetin concentrations in the subjects’ blood; however, BP, cholesterol, and resting HR 
showed no pre to post supplementation changes [21].                                                      
 Recent literature reveals a combination supplement containing quercetin, EGCG, 
omega-3 fatty acids, and resveratrol showed beneficial effects with an identical design to our 
study [10]. Kappus et al. used two weeks of a combination of flavanol supplementation and 
acute exercise and measured resultant resting and post-exercise variables, and demonstrated a 
marked decrease in BP during post-exercise hypotension [10].                                                
 In conclusion, the present study has found that two weeks of a multi-flavonoid 
antioxidant supplement can have favorable effects on the ANS by lowering the sympathetic 
outflow and potentially decreasing BP. While supplementation caused significant effects on 
the ANS, an acute bout of exercise elicited little change, which could be contributed to the 
fact that an acute bout is not enough to elicit effects on the cardiovascular system. These data 
indicate that supplementing with a proprietary multi-flavonoid supplement with fish oil could 
result in beneficial effects on the ANS in pre-hypertensive individuals.
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